Fetal outcomes in pregnant women with sickle cell disease

Mahmood D., Al Mendalawi; Mohammed N., Al Hunieni; Al Khabori Murtadha K.; Sharifa H., Al Farsi; Nihal M, Al Riyami.
Saudi Medical Journal. 2014; 35 (9): 1160-1161
en Inglés | IMEMR | ID: emr-154792

Documentos relacionados

  1. ¿Existe mayor riesgo de diabetes gestacional en pacientes con disfunción tiroidea autoinmune?
  2. Society for Maternal-Fetal Medicine Consult Series #68: Sickle cell disease in pregnancy.
  3. Executive summary. Consensus document of GESIDA and SPNS (Spanish Secretariat for the National Plan on AIDS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)
  4. Adverse pregnancy, fetal and neonatal outcomes in women with sickle cell disease in a Middle Eastern country.
  5. A comprehensive view of pregnancy in patients with sickle cell disease in high-income countries: the need for robust data and further decline in morbidity and mortality.
  6. Interleukin-6 in pregnancy with sickle cell disease.
  7. Interleukin-6 in pregnancy with sickle cell disease
  8. Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis.
  9. Chemokines in pregnant women with sickle cell disease.
  10. Outcomes of Pregnancy in Sickle Cell Disease Patients: Results from the Prospective ESCORT-HU Cohort Study.